Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: A modelling study using data from national surveys

by Adam Bennett, Donal Bisanzio, Joshua O Yukich et al.
The Lancet Glob Health, 2017 April; 5(4):e418-e427

10 pp. 822 kB
http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(17)30076-1.pdf

Artemisinin-based combination therapies (ACTs) are the most effective treatment for uncomplicated Plasmodium falciparum malaria infection. A commonly used indicator for monitoring and assessing progress in coverage of malaria treatment is the proportion of children younger than 5 years with reported fever in the previous 14 days who have received an ACT. Despite progress during the 2003–15 malaria programme, ACT treatment for children with malaria remains unacceptably low. More work is needed at the country level to understand how health-care access, service delivery, and ACT supply might be improved to ensure appropriate treatment for all children with malaria.

(Visited 15 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria, Maternal & Child Health. Bookmark the permalink.